Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bosch, Karin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thatikonda, Venu, Lu, Hengyu, Jurado, Sabine, Kostyrko, Kaja, Bristow, Christopher A., Bosch, Karin, Feng, Ningping, Gao, Sisi, Gerlach, Daniel, Gmachl, Michael, Lieb, Simone, Jeschko, Astrid, Machado, Annette A., Marszalek, Ethan D., Mahendra, Mikhila, Jaeger, Philipp A., Sorokin, Alexey, Strauss, Sandra, Trapani, Francesca, Kopetz, Scott, Vellano, Christopher P., Petronczki, Mark, Kraut, Norbert, Heffernan, Timothy P., Marszalek, Joseph R., Pearson, Mark, Waizenegger, Irene, Hofmann, Marco H.
Publikováno v:
bioRxiv
Efforts to improve the anti-tumor response to KRASG12Ctargeted therapy have benefited from leveraging combination approaches. Here, we compare the anti-tumor response induced by the SOS1-KRAS interaction inhibitor, BI-3406, combined with a KRASG12Cin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f6d27eb96463e3806b9270959c0a00
https://doi.org/10.1101/2023.01.23.525210
https://doi.org/10.1101/2023.01.23.525210
Autor:
van den Bosch, Karin E.1 karinvdbosch@gmail.com, Krzeminska, Anna2, Song, Eun Young3, van Hal, Lineke B. E.4, Waltz, Mitzi M.1,5, Ebben, Hannah1,6, Schippers, Alice P.1
Publikováno v:
Journal of Management & Organization. Jul2019, Vol. 25 Issue 4, p464-480. 17p.
Publikováno v:
None
Organisaties in het publieke domein zien steeds meer in dat om effectief te kunnen zenden, eerst actief moet worden ontvangen (van Woerkum & Aarts, 2008). De overheid gaat actief naar burgers toe om te horen wat er speelt en hen inzicht en inspraak t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::693ee4f2a12cdf66e0f720a88f07bd65
https://surfsharekit.nl/public/9f726c8d-b262-445b-8f66-c8a411376d07
https://surfsharekit.nl/public/9f726c8d-b262-445b-8f66-c8a411376d07
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Alive: Canada's Natural Health & Wellness Magazine; Jun2004, Issue 260, p10-12, 2p, 3 Color Photographs
Autor:
Chakroborty D; Institute of Biomedicine, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.; Turku Doctoral Programme of Molecular Medicine, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Ojala VK; Institute of Biomedicine, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.; Turku Doctoral Programme of Molecular Medicine, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Knittle AM; Institute of Biomedicine, University of Turku, Turku, Finland., Drexler J; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Tamirat MZ; Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, Åbo Akademi University, Turku, Finland.; Graduate School of Åbo Akademi University (Informational and Structural Biology Doctoral Network), Turku, Finland., Ruzicka R; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Bosch K; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Woertl J; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Schmittner S; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Elo LL; Institute of Biomedicine, University of Turku, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Johnson MS; Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Center, Åbo Akademi University, Turku, Finland., Kurppa KJ; Institute of Biomedicine, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Solca F; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Elenius K; Institute of Biomedicine, University of Turku, Turku, Finland.; Medicity Research Laboratories, University of Turku, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; Department of Oncology, Turku University Hospital, Turku, Finland.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Jan 07; Vol. 2 (1), pp. 10-27. Date of Electronic Publication: 2022 Jan 07 (Print Publication: 2022).